Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

  1. Tomaszewska, A.
  2. Jagasia, M.
  3. Beohou, E.
  4. van der Werf, S.
  5. Blaise, D.
  6. Kanfer, E.
  7. Milpied, N.
  8. Reményi, P.
  9. Ciceri, F.
  10. Bourhis, J.H.
  11. Chevallier, P.
  12. Solano, C.
  13. Socié, G.
  14. Bruno, B.
  15. Rambaldi, A.
  16. Castagna, L.
  17. Kröger, N.
  18. Corradini, P.
  19. Afanasyev, B.
  20. Ladetto, M.
  21. Niederwieser, D.
  22. Scheid, C.
  23. Sengeloev, H.
  24. Kroschinsky, F.
  25. Yakoub-Agha, I.
  26. Schoemans, H.
  27. Koenecke, C.
  28. Penack, O.
  29. Perić, Z.
  30. Greinix, H.
  31. Duarte, R.F.
  32. Basak, G.W.
  33. Mostra tots els autors/es +
Revista:
Frontiers in Immunology

ISSN: 1664-3224

Any de publicació: 2020

Volum: 11

Tipus: Article

DOI: 10.3389/FIMMU.2020.613954 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus